Header Logo

Connection

Cynthia Campbell to Humans

Back to Details
This is a "connection" page, showing publications Cynthia Campbell has written about Humans.
Cynthia Campbell
Connection Strength
2.317
Humans
  1. Clinical Use of Mental Health Digital Therapeutics in a Large Health Care Delivery System: Retrospective Patient Cohort Study and Provider Survey. JMIR Ment Health. 2024 Oct 02; 11:e56574.
    View in: PubMed
    Score: 0.068
  2. Changes in Prenatal Cannabis Use Among Pregnant Individuals From 2012 to 2022. Obstet Gynecol. 2024 Oct 01; 144(4):e101-e104.
    View in: PubMed
    Score: 0.068
  3. A patient activation intervention in primary care for patients with chronic pain on long term opioid therapy: results from a randomized control trial. BMC Health Serv Res. 2024 Jan 22; 24(1):112.
    View in: PubMed
    Score: 0.065
  4. Association of initial opioid prescription duration and an opioid refill by pain diagnosis: Evidence from outpatient settings in ten US health systems. Prev Med. 2024 Feb; 179:107828.
    View in: PubMed
    Score: 0.064
  5. Patient Engagement in a Multimodal Digital Phenotyping Study of Opioid Use Disorder. J Med Internet Res. 2023 06 13; 25:e45556.
    View in: PubMed
    Score: 0.062
  6. Overall and Telehealth Addiction Treatment Utilization by Age, Race, Ethnicity, and Socioeconomic Status in California After COVID-19 Policy Changes. JAMA Health Forum. 2023 05 05; 4(5):e231018.
    View in: PubMed
    Score: 0.062
  7. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9.
    View in: PubMed
    Score: 0.053
  8. Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study. BMC Health Serv Res. 2020 Nov 11; 20(1):1030.
    View in: PubMed
    Score: 0.052
  9. Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system. J Subst Abuse Treat. 2020 11; 118:108097.
    View in: PubMed
    Score: 0.051
  10. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose. Drug Alcohol Depend. 2020 04 01; 209:107923.
    View in: PubMed
    Score: 0.049
  11. Characteristics of patients with substance use disorder before and after the Affordable Care Act. Drug Alcohol Depend. 2018 12 01; 193:124-130.
    View in: PubMed
    Score: 0.045
  12. Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system. Prev Med. 2018 05; 110:31-37.
    View in: PubMed
    Score: 0.043
  13. Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters. Subst Abus. 2018 01 02; 39(1):59-68.
    View in: PubMed
    Score: 0.042
  14. Smoking Status and Opioid-related Problems and Concerns Among Men and Women on Chronic Opioid Therapy. Clin J Pain. 2017 Aug; 33(8):730-737.
    View in: PubMed
    Score: 0.041
  15. Serious mental illness and medical comorbidities: Findings from an integrated health care system. J Psychosom Res. 2017 09; 100:35-45.
    View in: PubMed
    Score: 0.041
  16. The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend. 2017 09 01; 178:170-175.
    View in: PubMed
    Score: 0.041
  17. Prescription opioid registry protocol in an integrated health system. Am J Manag Care. 2017 May 01; 23(5):e146-e155.
    View in: PubMed
    Score: 0.041
  18. Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System. J Psychoactive Drugs. 2017 Apr-Jun; 49(2):160-168.
    View in: PubMed
    Score: 0.041
  19. The high price of depression: Family members' health conditions and health care costs. Gen Hosp Psychiatry. 2017 05; 46:79-87.
    View in: PubMed
    Score: 0.040
  20. Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy. Subst Use Misuse. 2017 08 24; 52(10):1283-1291.
    View in: PubMed
    Score: 0.040
  21. Socioeconomic differences in adolescent substance abuse treatment participation and long-term outcomes. Addict Behav. 2017 05; 68:45-51.
    View in: PubMed
    Score: 0.040
  22. Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. J Addict Med. 2017 Jan/Feb; 11(1):3-9.
    View in: PubMed
    Score: 0.040
  23. Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):e76-e82.
    View in: PubMed
    Score: 0.040
  24. Marijuana use and service utilization among adolescents 7 years post substance use treatment. Drug Alcohol Depend. 2016 Nov 01; 168:1-7.
    View in: PubMed
    Score: 0.039
  25. Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California. Am J Public Health. 2016 07; 106(7):1211-3.
    View in: PubMed
    Score: 0.038
  26. High-Deductible Health Plans: Implications for Substance Use Treatment. Health Serv Res. 2016 10; 51(5):1939-59.
    View in: PubMed
    Score: 0.037
  27. 12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug Alcohol Depend. 2012 Nov 01; 126(1-2):124-30.
    View in: PubMed
    Score: 0.029
  28. Peer influences on adolescent alcohol and other drug use outcomes. J Nurs Scholarsh. 2012 Mar; 44(1):36-44.
    View in: PubMed
    Score: 0.028
  29. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010 Dec; 100(12):2541-7.
    View in: PubMed
    Score: 0.026
  30. Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat. 2009 Jul; 37(1):64-72.
    View in: PubMed
    Score: 0.023
  31. Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization. Addict Behav. 2009 Feb; 34(2):171-9.
    View in: PubMed
    Score: 0.022
  32. Tailoring of outpatient substance abuse treatment to women, 1995-2005. Med Care. 2007 Aug; 45(8):775-80.
    View in: PubMed
    Score: 0.021
  33. Tailored treatment in the outpatient substance abuse treatment sector: 1995-2005. J Subst Abuse Treat. 2008 Apr; 34(3):282-92.
    View in: PubMed
    Score: 0.021
  34. Do licensing and accreditation matter in outpatient substance abuse treatment programs? J Subst Abuse Treat. 2007 Jul; 33(1):43-50.
    View in: PubMed
    Score: 0.020
  35. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J Adolesc Health. 2006 Apr; 38(4):343-50.
    View in: PubMed
    Score: 0.019
  36. Availability of services for women in outpatient substance abuse treatment: 1995-2000. J Behav Health Serv Res. 2006 Jan; 33(1):1-19.
    View in: PubMed
    Score: 0.019
  37. Health services for women in outpatient substance abuse treatment. Health Serv Res. 2005 Jun; 40(3):781-810.
    View in: PubMed
    Score: 0.018
  38. Association of Local Cannabis Policy and Retail Availability With Cannabis Use and Problematic Cannabis Use Among Adolescents in Northern California. Am J Public Health. 2024 Nov; 114(S8):S654-S663.
    View in: PubMed
    Score: 0.017
  39. Cannabis Use During Early Pregnancy Following Recreational Cannabis Legalization. JAMA Health Forum. 2024 Nov 01; 5(11):e243656.
    View in: PubMed
    Score: 0.017
  40. Prospective changes in drinking during the COVID-19 pandemic among adults with unhealthy alcohol use. Alcohol Alcohol. 2024 Sep 21; 59(6).
    View in: PubMed
    Score: 0.017
  41. Prevalence and trends of suspected cannabinoid hyperemesis syndrome over an 11-year period in Northern California: An electronic health record study. Drug Alcohol Depend. 2024 Oct 01; 263:112418.
    View in: PubMed
    Score: 0.017
  42. Opioid Administration Practice Patterns in Patients With Acute Respiratory Failure Who Undergo Invasive Mechanical Ventilation. Crit Care Explor. 2024 Jul 01; 6(7):e1123.
    View in: PubMed
    Score: 0.017
  43. Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial. Drug Alcohol Depend. 2024 Aug 01; 261:111350.
    View in: PubMed
    Score: 0.017
  44. Intravenous Opioid Administration During Mechanical Ventilation and Use After Hospital Discharge. JAMA Netw Open. 2024 Jun 03; 7(6):e2417292.
    View in: PubMed
    Score: 0.017
  45. Clinician perspectives on adolescent cannabis-related beliefs and behaviors following recreational cannabis legalization. Addict Behav. 2024 09; 156:108046.
    View in: PubMed
    Score: 0.016
  46. Self-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study. Medicine (Baltimore). 2024 Mar 29; 103(13):e37581.
    View in: PubMed
    Score: 0.016
  47. Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus. Addict Sci Clin Pract. 2024 Feb 28; 19(1):14.
    View in: PubMed
    Score: 0.016
  48. Changes in managed care activity in outpatient substance abuse treatment organizations, 1995-2000. J Behav Health Serv Res. 2003 Oct-Dec; 30(4):369-81.
    View in: PubMed
    Score: 0.016
  49. Administrative burden and its implications for outpatient substance abuse treatment organizations. Psychiatr Serv. 2003 May; 54(5):705-11.
    View in: PubMed
    Score: 0.015
  50. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013 Mar 06; 105(5):350-60.
    View in: PubMed
    Score: 0.015
  51. Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systems. BMC Health Serv Res. 2022 Dec 29; 22(1):1593.
    View in: PubMed
    Score: 0.015
  52. COVID-19 pandemic-related changes in utilization of telehealth and treatment overall for alcohol use problems. Alcohol Clin Exp Res. 2022 12; 46(12):2280-2291.
    View in: PubMed
    Score: 0.015
  53. Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Drug Alcohol Depend. 2023 Jan 01; 242:109711.
    View in: PubMed
    Score: 0.015
  54. Patterns of Health Care Use 5 Years After an Intervention Linking Patients in Addiction Treatment With a Primary Care Practitioner. JAMA Netw Open. 2022 11 01; 5(11):e2241338.
    View in: PubMed
    Score: 0.015
  55. Geographic Accessibility of Retail Cannabis in Northern California and Prenatal Cannabis Use During the COVID-19 Pandemic. JAMA Netw Open. 2022 11 01; 5(11):e2244086.
    View in: PubMed
    Score: 0.015
  56. Development and Testing of a Communication Intervention to Improve Chronic Pain Management in Primary Care: A Pilot Randomized Clinical Trial. Clin J Pain. 2022 10 01; 38(10):620-631.
    View in: PubMed
    Score: 0.015
  57. Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients. JAMA Netw Open. 2022 05 02; 5(5):e2211677.
    View in: PubMed
    Score: 0.014
  58. Alcohol brief intervention, specialty treatment and drinking outcomes at 12 months: Results from a systematic alcohol screening and brief intervention initiative in adult primary care. Drug Alcohol Depend. 2022 Jun 01; 235:109458.
    View in: PubMed
    Score: 0.014
  59. Culturally competent treatment practices and ancillary service use in outpatient substance abuse treatment. J Subst Abuse Treat. 2002 Apr; 22(3):109-19.
    View in: PubMed
    Score: 0.014
  60. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis. 2012 Apr; 54(7):1026-34.
    View in: PubMed
    Score: 0.014
  61. Clinical documentation of patient-reported medical cannabis use in primary care: Toward scalable extraction using natural language processing methods. Subst Abus. 2022; 43(1):917-924.
    View in: PubMed
    Score: 0.014
  62. Changes in Diagnostic and Demographic Characteristics of Patients Seeking Mental Health Care During the Early COVID-19 Pandemic in a Large, Community-Based Health Care System. J Clin Psychiatry. 2021 03 03; 82(2).
    View in: PubMed
    Score: 0.013
  63. Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV. J Gen Intern Med. 2021 04; 36(4):930-937.
    View in: PubMed
    Score: 0.013
  64. Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study. Trials. 2021 Jan 28; 22(1):102.
    View in: PubMed
    Score: 0.013
  65. Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies. J Addict Med. 2020 12; 14(6):e293-e296.
    View in: PubMed
    Score: 0.013
  66. Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine. 2020 06 15; 38(29):4520-4523.
    View in: PubMed
    Score: 0.013
  67. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2020 03; 112S:4-11.
    View in: PubMed
    Score: 0.012
  68. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems. J Subst Abuse Treat. 2020 03; 112S:41-48.
    View in: PubMed
    Score: 0.012
  69. Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness. BMC Psychiatry. 2020 01 31; 20(1):40.
    View in: PubMed
    Score: 0.012
  70. Long-term opioid therapy definitions and predictors: A systematic review. Pharmacoepidemiol Drug Saf. 2020 03; 29(3):252-269.
    View in: PubMed
    Score: 0.012
  71. Postoperative Opioid Use Before and After Enhanced Recovery After Surgery Program Implementation. Ann Surg. 2019 12; 270(6):e69-e71.
    View in: PubMed
    Score: 0.012
  72. Benzodiazepine and unhealthy alcohol use among adult outpatients. Am J Manag Care. 2019 12 01; 25(12):e358-e365.
    View in: PubMed
    Score: 0.012
  73. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020 02 01; 207:107732.
    View in: PubMed
    Score: 0.012
  74. Enhanced Recovery After Surgery to Change Process Measures and Reduce Opioid Use After Cesarean Delivery: A Quality Improvement Initiative. Obstet Gynecol. 2019 09; 134(3):511-519.
    View in: PubMed
    Score: 0.012
  75. Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med. 2009 Sep; 24(9):1065-72.
    View in: PubMed
    Score: 0.012
  76. Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy. J Pain Symptom Manage. 2009 Aug; 38(2):197-207.
    View in: PubMed
    Score: 0.012
  77. Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection. Ann Intern Med. 2009 Mar 03; 150(5):301-13.
    View in: PubMed
    Score: 0.012
  78. Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? Curr Opin HIV AIDS. 2009 Jan; 4(1):42-51.
    View in: PubMed
    Score: 0.011
  79. Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. J Affect Disord. 2018 12 01; 241:8-14.
    View in: PubMed
    Score: 0.011
  80. Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder. Psychiatry Res. 2018 01; 259:316-322.
    View in: PubMed
    Score: 0.010
  81. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol. 2007 Sep; 19(5):446-51.
    View in: PubMed
    Score: 0.010
  82. Association of the Affordable Care Act With Smoking and Tobacco Treatment Utilization Among Adults Newly Enrolled in Health Care. Med Care. 2017 05; 55(5):535-541.
    View in: PubMed
    Score: 0.010
  83. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007 Apr 09; 167(7):684-91.
    View in: PubMed
    Score: 0.010
  84. Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records. Pharmacoepidemiol Drug Saf. 2017 May; 26(5):509-517.
    View in: PubMed
    Score: 0.010
  85. Effectiveness of highly-active antiretroviral therapy by race/ethnicity. AIDS. 2006 Jul 13; 20(11):1531-8.
    View in: PubMed
    Score: 0.010
  86. Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties. BMC Pharmacol Toxicol. 2016 05 14; 17(1):21.
    View in: PubMed
    Score: 0.009
  87. Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Clin Vaccine Immunol. 2006 Apr; 13(4):511-9.
    View in: PubMed
    Score: 0.009
  88. Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract. 2015 Nov 19; 10:26.
    View in: PubMed
    Score: 0.009
  89. Sex and Age Differences in Global Pain Status Among Patients Using Opioids Long Term for Chronic Noncancer Pain. J Womens Health (Larchmt). 2015 Aug; 24(8):629-35.
    View in: PubMed
    Score: 0.009
  90. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis. 2004 Sep 01; 39(5):717-24.
    View in: PubMed
    Score: 0.008
  91. Do patient-perceived pros and cons of opioids predict sustained higher-dose use? Clin J Pain. 2014 Feb; 30(2):93-101.
    View in: PubMed
    Score: 0.008
  92. 12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity. Subst Abus. 2013; 34(1):33-42.
    View in: PubMed
    Score: 0.008
  93. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry. 2012 Nov-Dec; 34(6):581-7.
    View in: PubMed
    Score: 0.007
  94. Depression and ambivalence toward chronic opioid therapy for chronic noncancer pain. Clin J Pain. 2012 Sep; 28(7):561-6.
    View in: PubMed
    Score: 0.007
  95. Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med. 2012 Jul-Aug; 10(4):304-11.
    View in: PubMed
    Score: 0.007
  96. Twelve-Step attendance trajectories over 7 years among adolescents entering substance use treatment in an integrated health plan. Addiction. 2012 May; 107(5):933-42.
    View in: PubMed
    Score: 0.007
  97. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012 Mar; 13(3):266-75.
    View in: PubMed
    Score: 0.007
  98. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012 Jan; 28(1):39-46.
    View in: PubMed
    Score: 0.007
  99. Functional disability among chronic pain patients receiving long-term opioid treatment. J Soc Work Disabil Rehabil. 2012; 11(2):128-42.
    View in: PubMed
    Score: 0.007
  100. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2551-9.
    View in: PubMed
    Score: 0.007
  101. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain. 2011 Jun; 152(6):1256-62.
    View in: PubMed
    Score: 0.007
  102. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010 Jan 19; 152(2):85-92.
    View in: PubMed
    Score: 0.006
  103. Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan. Int J Psychiatry Med. 2010; 40(1):57-76.
    View in: PubMed
    Score: 0.006
  104. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1166-75.
    View in: PubMed
    Score: 0.006
  105. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009 Nov 13; 23(17):2337-45.
    View in: PubMed
    Score: 0.006
  106. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009 Nov-Dec; 31(6):564-70.
    View in: PubMed
    Score: 0.006
  107. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009 Oct; 145(3):287-93.
    View in: PubMed
    Score: 0.006
  108. Three-year chemical dependency and mental health treatment outcomes among adolescents: the role of continuing care. Alcohol Clin Exp Res. 2009 Aug; 33(8):1417-29.
    View in: PubMed
    Score: 0.006
  109. Twelve-Step affiliation and 3-year substance use outcomes among adolescents: social support and religious service attendance as potential mediators. Addiction. 2009 Jun; 104(6):927-39.
    View in: PubMed
    Score: 0.006
  110. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008 Jul-Aug; 24(6):521-7.
    View in: PubMed
    Score: 0.006

© 2025 Kaiser Permanente